Maryland, 27 June 2024: The US Food and Drug Administration (FDA) published a much-anticipated draft guidance that recommends more diverse patient cohorts in clinical trials and is meant to improve the data the agency receives in support of premarket applications. It broadly desc......
View Details

Related News

• Zydus and Dr. Reddy’s announce licensing agreement for co-marketing of Pertuzumab biosimilar (30-06-2024)

---

• FDA starts probe into ‘foreign particle’ in saline bottle (30-06-2024)

---

• 80% of public health facilities are substandard: Govt survey (29-06-2024)

---

• FSSAI to release tighter regulations for Protein Supplements (29-06-2024)

---

• Kerala govt issues warning on infectious diseases (29-06-2024)

---

• Most kids and teens with conjunctivitis prescribed unnecessary antibiotics despite guidelines: Study (29-06-2024)

---

• Urgent need to strengthen quality management system, documentation & validation processes: DCGI (29-06-2024)

---

• India to make Ozempic-like drugs for diabetes, obesity under PLI by 2026 (29-06-2024)

---

• Orchid Pharma partners with Cipla to launch antibiotic Cefepime-Enmetazobactam in India (28-06-2024)

---

• DCA Telangana seizes spurious 'Vertin Tabs', overpriced 'Itragril-200 Caps' and 3 drugs for misleading claims (28-06-2024)

---